| Citation: |
ZHOU Silei, SUN Guanqun, ZENG Tanlun, CHENG Zhuo, LIANG Xijun. Expression and Prognostic Value of CK2α' in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 662-666. DOI: 10.3971/j.issn.1000-8578.2022.21.1291
|
To investigate the expression of CK2α' in hepatocellular carcinoma (HCC) tissues and its prognosis value.
Tissue microarray was made from tumor and adjacent normal tissues of 83 patients with HCC. Immunohistochemical was used to stain the microarray for semi-quantitative analysis, and the expression of CK2α' in HCC tissues and adjacent normal tissues was compared. The associations between CK2α' expression and clinicopathologic features of HCC patients were analyzed with χ2 text. The prognostic value of CK2α' was estimated using Kaplan-Meier approach.
The average positive expression rate of CK2α' was 47.8% in HCC and 65.4% in adjacent normal tissues. The positive expression rate of CK2α' in HCC tissues was lower than that in adjacent normal tissues (P < 0.01). The expression level of CK2α' in the cancer tissues of 74.7% cases was significantly lower than that in the adjacent tissues. HCC patients with low CK2α' expression had higher risk of recurrence and shorter overall survival time (P < 0.05). The expression of CK2α' was significantly correlated with CK19 (P < 0.05).
CK2α' is down-regulated in HCC tissues and correlated with the prognosis of patients. It could be a potential prognostic marker for HCC.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Liu Y, Veeraraghavan V, Pinkerton M, et al. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence[J]. Front Microbiol, 2021, 12: 665201. doi: 10.3389/fmicb.2021.665201
|
| [2] |
Zhang Z, Chen P, Xie H, et al. Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma[J]. Front Oncol, 2021, 11: 654185. doi: 10.3389/fonc.2021.654185
|
| [3] |
Borgo C, D'Amore C, Sarno S, et al. Protein kinase CK2: a potential therapeutic target for diverse human diseases[J]. Signal Transduct Target Ther, 2021, 6(1): 183.
|
| [4] |
Chua M, Lee M, Dominguez IM. Cancer-type dependent expression of CK2 transcripts[J]. PLos One, 2017, 12(12): e0188854. doi: 10.1371/journal.pone.0188854
|
| [5] |
Roffey SE, Litchfield DW. CK2 Regulation: Perspectives in 2021[J]. Biomedicines, 2021, 9(10): 1361. doi: 10.3390/biomedicines9101361
|
| [6] |
Seongrak K, Sunyoung H, Kyungmi Y, et al. Protein kinase CK2 activation is required for transforming growth factor-β-induced epithelial-mesenchymal transition[J]. Mol Oncol, 2018, 12(10): 1811-1826. doi: 10.1002/1878-0261.12378
|
| [7] |
de Villavicencio-Diaz TN, Rabalski AJ, Litchfield DW. Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks[J]. Pharmaceuticals (Basel)2017, 10(1): 27.
|
| [8] |
Pinna LA. Protein kinase CK2: a challenge to canons[J]. J Cell Sci, 2002, 115(Pt 20): 3873-3878.
|
| [9] |
Borgo C, Ruzzene M. Role of protein kinase CK2 in antitumor drug resistance[J]. J Exp Clin Cancer Res, 2019, 38(1): 287. doi: 10.1186/s13046-019-1292-y
|
| [10] |
Dominguez I, Mizuno J, Wu H, et al. A role for CK2alpha/beta in Xenopus early embryonic development[J]. Mol Cell Biochem, 2005, 274(1-2): 125-131. doi: 10.1007/s11010-005-3073-5
|
| [11] |
Dominguez I, Mizuno J, Wu H, et al. Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos[J]. Dev Biol, 2004, 274(1): 110-124. doi: 10.1016/j.ydbio.2004.06.021
|
| [12] |
Hong H, Benveniste EN. The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer[J]. Biomedicines, 2021, 9(12): 1932. doi: 10.3390/biomedicines9121932
|
| [13] |
Channavajhala P, Seldin DC. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis[J]. Oncogene, 2002, 21(34): 5280-5288.
|
| [14] |
Gomes AM, Soares MV, Ribeiro P, et al. Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels[J]. Haematologica, 2014, 99(6): 1062-1068.
|
| [15] |
Storz MN, van de Rijn M, Kim YH, et al. Gene expression profiles of cutaneous B cell lymphoma[J]. J Invest Dermatol, 2003, 120(5): 865-870.
|
| [16] |
Lian H, Su M, Zhu Y, et al. Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management[J]. Asian Pac J Cancer Prev, 2019, 20(1): 23-32.
|
| [17] |
安晓刚, 马万龙, 马玉, 等. 血清细胞角蛋白19检测在原发性肝癌中的应用价值[J]. 宁夏医科大学学报, 2018, 40(2): 211-213. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY201802024.htm
An XG, Ma WL, Ma Y, et al. Application value of serum cytokeratin 19 in primary liver cancer[J]. Ningxia Yi Ke Da Xue Xue Bao, 2018, 40(2): 211-213. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY201802024.htm
|
| [18] |
Chen Y, Chen J, Zhang Y, et al. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging[J]. J Hepatocell Carcinoma, 2021, 8: 795-808.
|
| [19] |
Piñero F, Dirchwolf M, Pessôa MG. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment[J]. Cells, 2020, 9(6): 1370.
|
Figures(2) / Tables(1)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: